Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11.2M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
20.9M
-
Shares change
-
-188K
-
Total reported value, excl. options
-
$272M
-
Value change
-
-$3.15M
-
Number of buys
-
21
-
Number of sells
-
-13
-
Price
-
$12.62
Significant Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q3 2021
44 filings reported holding IKNA - Ikena Oncology, Inc. - Common Stock, $0.001 par value as of Q3 2021.
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.9M shares
.
Largest 10 shareholders include FMR LLC (5.03M shares), ORBIMED ADVISORS LLC (2.93M shares), Omega Fund Management, LLC (2.25M shares), CITADEL ADVISORS LLC (2.13M shares), BVF INC/IL (1.83M shares), Artal Group S.A. (1.55M shares), FARALLON CAPITAL MANAGEMENT LLC (1.12M shares), RA CAPITAL MANAGEMENT, L.P. (750K shares), VANGUARD GROUP INC (621K shares), and BlackRock Inc. (484K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.